NPI registry status
Active
2026 NPPES data Otolaryngology Physician NPI 1821252974 MD
Verify on CMS → Jeffrey Bedrosian, MD
Otolaryngology Physician in Portland, Maine.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,893 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
674
Medicare Part D claims · 235 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.6/100
▲ 13 pts above national avg 83.1 · Exceptional
Industry payments
$180.6K
197 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Jeffrey Bedrosian, MD reported a CMS MIPS final score of 95.6/100 - above the 83.1 national average - and filed 674 Medicare Part D claims in 2023.
- 95.6/100
- MIPS score · +13 vs avg
- 674
- Part D claims, 2023
- 98%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jeffrey Bedrosian, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
96 Top 21% higher than 79% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jeffrey Bedrosian, MD sits
This provider among otolaryngology physician peers
Across the 3,669 otolaryngology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jeffrey Bedrosian, MD writes more Part D claims than 66% of them and scores higher on MIPS quality than 87% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one otolaryngology physician peer from a representative sample of 60; the gold marker is Jeffrey Bedrosian, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jeffrey Bedrosian, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jeffrey Bedrosian, MD?
High performer (top quartile)Primary specialty
Otolaryngology Physician
Medicare Part D claims
674 32% vs specialty avg
MIPS final score
95.6/100 12.5 pts vs avg
Specialty distribution in Maine
How Otolaryngology Physician compares to other specialties among Maine providers
Medicare quality performance, MIPS
Jeffrey Bedrosian, MD's 2023 MIPS final score plotted against the Otolaryngology Physician national average
- MIPS Final Score
- 95.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Otolaryngology Physician) - 95.6/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jeffrey Bedrosian, MD appears in the CMS NPPES registry as an Otolaryngology Physician provider holding MD credentials at 1250 FOREST AVE, Portland, ME, 04103, with a listed phone of (207) 797-5753. NPI 1821252974 was issued on 07/17/2008.
Medicare Part D records for calendar year 2023 show 674 prescription claims written by this provider, covering 235 Medicare beneficiaries and totaling roughly $19K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 3.0%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.6/100 for the 2023 performance year (Quality 80.6), compared with the national average of 83.1.
Otolaryngology Physician is a mid-sized specialty nationwide, with 10,893 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1821252974 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/17/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
95.6426
Final Score
Avg: 83.1
80.5735
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Jeffrey Bedrosian, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Specialty Physician Associates, LLC
Bethlehem, PA
St Lukes Warren Physician Group PC
Washington, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jeffrey Bedrosian, MD. Source: openpaymentsdata.cms.gov.
Total received
$180.6K
Largest payer
Optinose US, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Jeffrey Bedrosian, MD - brand share 2.0%
Otolaryngology Physician average
2% brand-name claims vs 98% generic, on 674 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
674
Total Claims
$19K
Total Drug Cost
235
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,104
- Total Day Supply
- 30,272
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $4K
- Generic Drug Cost
- $15K
- Opioid Claims
- 20 (3.0% rate)
- Antibiotic Claims
- 73
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 17, 65-74: 113, 75-84: 85, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jeffrey Bedrosian, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Famotidine
Famotidine
215 claims
- Ipratropium Bromide
Ipratropium Bromide
130 claims
- Pantoprazole Sodium 49
Pantoprazole Sodium
49 claims
- Omeprazole 48
Omeprazole
48 claims
- Amoxicillin-Clavul… 22
Amoxicillin-Clavulanate Potass
22 claims
- Nortriptyline Hcl 20
Nortriptyline Hcl
20 claims
- Fluticasone Propio… 18
Fluticasone Propionate
18 claims
- Prednisone 18
Prednisone
18 claims
| Drug | Claims |
|---|---|
| Famotidine | 215 |
| Ipratropium Bromide | 130 |
| Pantoprazole Sodium | 49 |
| Omeprazole | 48 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 22 |
| Nortriptyline Hcl | 20 |
| Fluticasone Propionate | 18 |
| Prednisone | 18 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 17 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How Jeffrey Bedrosian, MD fits within the Otolaryngology Physician landscape nationally.
10,893
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider
Jeffrey Bedrosian, MD's 674 claims are above the specialty average of 509.
Nearby Otolaryngology Physician Providers in Maine
Other clinicians with the same primary specialty enrolled in Maine, drawn from the same CMS NPPES roster as Bedrosian.
Dr. Demetri Antoniou
M.D.,D.M.D.
Portland, ME
Dr. G. Chamberlin
MD
Rockport, ME
Dr. William Chasse
MD
Waterville, ME
Dr. Brandon Chiu
M.D.
South Portland, ME
Dr. Brian Cusick
MD
Augusta, ME
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Maine medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Otolaryngology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Maine
Frequently Asked Questions
What is Jeffrey Bedrosian, MD's specialty? ▼
Jeffrey Bedrosian, MD specializes in Otolaryngology Physician and practices in Portland, Maine. Credentials: MD.
How much does Jeffrey Bedrosian, MD prescribe under Medicare Part D? ▼
In 2023, Jeffrey Bedrosian, MD wrote 674 Medicare Part D claims totaling $19K in drug costs for 235 beneficiaries.
What is Jeffrey Bedrosian, MD's Medicare quality score? ▼
Jeffrey Bedrosian, MD has a CMS MIPS Final Score of 95.6/100 (Quality: 80.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jeffrey Bedrosian, MD located? ▼
Jeffrey Bedrosian, MD is located at 1250 FOREST AVE, Portland, ME, 04103. Phone: (207) 797-5753.
What is Jeffrey Bedrosian, MD's NPI number? ▼
Jeffrey Bedrosian, MD's National Provider Identifier (NPI) is 1821252974, issued on 07/17/2008.
Does Jeffrey Bedrosian, MD prescribe more brand-name or generic drugs? ▼
Jeffrey Bedrosian, MD's prescribing is 2% brand-name and 98% generic drugs by claim count, with $4K in brand drug costs.
Does Jeffrey Bedrosian, MD prescribe opioids? ▼
Yes, Jeffrey Bedrosian, MD had 20 opioid claims in 2023 with an opioid prescribing rate of 3.0%.
How many Otolaryngology Physician providers are there in the US? ▼
There are 10,893 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does Jeffrey Bedrosian, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Jeffrey Bedrosian, MD's most frequently prescribed drugs include Famotidine, Ipratropium Bromide, Pantoprazole Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeffrey Bedrosian, MD accept Medicare? ▼
Jeffrey Bedrosian, MD appears in CMS Medicare data with 674 Part D claims and 235 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeffrey Bedrosian, MD's credentials? ▼
Jeffrey Bedrosian, MD's NPI is 1821252974 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.